<DOC>
	<DOCNO>NCT00316680</DOCNO>
	<brief_summary>A trial characterize immunogenicity 2 different formulation vaccine GSK Biologicals , include follow five antigen : diphtheria , tetanus , pertussis , hepatitis B Haemophilus influenzae type b . A vaccine Commonwealth Serum Laboratories ( diphtheria , tetanus , pertussis ) co-administered Haemophilus influenzae type b vaccine also use comparator . Reactogenicity safety vaccine assess well .</brief_summary>
	<brief_title>Immuno &amp; Safety Study With 2 Formulations DTPw-HBV/HIB When Given Birth With Hepatitis B 2 , 4 6 Mths.Age .</brief_title>
	<detailed_description>`` The study carry partially double blind manner ( i.e . double blind respect DTPwGöd-HBV/Hib Kft DTPwCSL-HBV/Hib Kft group open respect CSL 's Triple Antigen &amp; Hib group ) . Subjects randomly allocate one three follow group receive : - GSK Biologicals Kft 's combined DTPwGöd-HBV/Hib Kft vaccine . - GSK Biologicals Kft 's combined DTPwCSL-HBV/Hib Kft vaccine . - CSL 's Triple Antigen + GSK Biologicals ' Hib vaccine . There specific follow-up solicit local general symptom 4 day vaccination unsolicited symptom 31 day vaccination . Serious adverse event report study period record .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion criterion Administration one dose hepatitis B vaccine birth . A healthy male female , include , 6 12 week age time first DTPw vaccination . Exclusion criterion Use investigational nonregistered product ( drug vaccine ) study vaccine ( ) within 30 day precede first dose study vaccine , plan use study period . Chronic administration immunosuppressant immunemodifying drug since birth . Planned administration/ administration vaccine foreseen study protocol within 30 day first vaccine dose plan administration study period exception oral polio vaccine hepatitis B vaccine Triple Antigen + Hib group . Any confirm suspected immunosuppressive immunodeficient condition base medical history physical examination ( laboratory testing require ) Administration immunoglobulins and/or blood product since birth plan administration study period . Bacille CalmetteGuérin ( BCG ) vaccine give first 2 week life . Previous vaccination diphtheria , tetanus , pertussis and/or Hib/History diphteria , tetanus , pertussis , hepatitis B and/ hib disease .</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>12 Weeks</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>